India, March 29 -- If you're looking at a 100cc commuter, chances are you're not chasing performance or features. You just want something that starts every morning, feels easy in traffic, and most imp... Read More
Afghanistan, March 29 -- Thousands of Americans rallied nationwide on Saturday, denouncing Donald Trump's policies, expanding presidential power, immigration crackdowns and the war with Iran. Thousan... Read More
Nigeria, March 29 -- Palm Sunday is not just a date on the calendar. It is a scene, a tension, a beginning that carries its ending within it. The streets of Jerusalem are alive with expectation. The a... Read More
Nigeria, March 29 -- A pastor in Anambra State has been detained at the State Criminal Investigation Department (SCID) of the police for allegedly raping and impregnating a 16-year-old girl in the sta... Read More
India, March 29 -- The upcoming elections to the Tripura Tribal Areas Autonomous District Council (TTAADC) are poised for a multi-cornered contest, with all major political parties fielding candidates... Read More
India, March 29 -- Solid waste management in Manipur, particularly in Imphal, faces severe challenges, with current systems relying on conventional collection and disposal methods. Efforts are now un... Read More
Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More
Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More
Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More
Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More